Ancor-A Tablet is a combination of amlodipine and bisoprolol fumarate, belonging to the antihypertensive class of medicines. It is indicated for the treatment of hypertension in patients whose blood pressure is already adequately controlled with the same doses of amlodipine and bisoprolol taken separately. This fixed-dose combination provides the convenience of taking both medicines in a single tablet.
Ancor-A is not recommended during pregnancy or breastfeeding unless specifically prescribed by a physician after careful assessment of the potential benefits and risks.
১০০% অরিজিনাল পণ্যের নিশ্চয়তা
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Amlodipine is a dihydropyridine calcium channel blocker. It reduces the movement of calcium ions into vascular smooth muscle cells, causing the blood vessels to relax and widen. This decreases peripheral vascular resistance and subsequently lowers blood pressure.
Bisoprolol fumarate is a selective beta-1 adrenergic receptor blocker. It primarily acts on the heart by reducing heart rate and cardiac workload. At therapeutic doses, it has considerably greater selectivity for beta-1 receptors than beta-2 receptors, helping to limit effects on the airways and metabolic processes.
Together, amlodipine and bisoprolol provide complementary blood-pressure-lowering effects.
- Elderly: Usual doses may generally be used, but additional caution is recommended when increasing the dose.
- Children and adolescents: The safety and effectiveness of the amlodipine/bisoprolol combination have not been established in patients below 18 years of age.
- Liver disease: Amlodipine may be eliminated more slowly in patients with hepatic impairment. It should therefore be used with particular caution. In severe hepatic impairment, the daily bisoprolol dose should not exceed 10 mg.
- Kidney disease: No dosage adjustment is generally required for mild to moderate renal impairment. Amlodipine is not removed by dialysis and should be used cautiously in patients undergoing dialysis. In severe renal impairment with creatinine clearance below 20 mL/min, the daily bisoprolol dose should not exceed 10 mg.
The usual dose is one tablet once daily, provided that the patient's blood pressure has already been adequately controlled with the same doses of amlodipine and bisoprolol administered as separate medicines.
Take the medicine exactly as prescribed by your doctor and preferably at the same time each day.
An overdose of bisoprolol may cause slow heart rate, low blood pressure, bronchospasm, acute heart failure, and low blood glucose.
Excessive amlodipine exposure may cause marked widening of blood vessels, potentially resulting in severe and prolonged hypotension, sometimes accompanied by reflex tachycardia. Severe overdose can be life-threatening.
If an overdose is suspected, seek immediate medical attention. Treatment generally involves stopping the medicine and providing appropriate supportive and symptomatic care.
Ancor-A may interact with several medicines.
Combinations generally not recommended:
Use with caution:
Other medicines that may require consideration include mefloquine, rifampicin, ergotamine derivatives, and MAO inhibitors other than MAO-B inhibitors.
Common side effects may include:
Uncommon side effects may include:
Rare side effects may include:
Ancor-A should be used cautiously in patients with heart failure, as further deterioration of cardiac pumping function may occur.
Do not stop bisoprolol suddenly. Abrupt discontinuation may temporarily worsen the patient's condition, particularly in those with ischemic heart disease. Treatment should generally be reduced gradually under medical supervision.
Special caution is required in patients with:
Bisoprolol may mask some symptoms of hypoglycemia and thyrotoxicosis. Patients with diabetes should monitor their blood glucose regularly.
If surgery requiring general anesthesia is planned, inform the anesthetist that you are taking a beta-blocker. If discontinuation is considered necessary before surgery, it should generally be done gradually and completed approximately 48 hours before anesthesia.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.